Raymond James Starts Sarepta Therapeutics (SRPT) at Outperform
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $23.21 +8.81%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Raymond James analyst Danielle Brill initiates coverage on Sarepta Therapeutics (NASDAQ: SRPT) with a Outperform rating and a price target of $200.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.
Shares of Sarepta Therapeutics closed at $141.94 yesterday.
You May Also Be Interested In
- Scotiabank Starts Webull (BULL) at Sector Outperform
- Canaccord Starts BillionToOne Inc (BLLN) at Buy
- William Blair Resumes uniQure BV (QURE) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
